Sort
8,912 grants matching “sars cov 2”
Protein Expression Facility
$1,629,843Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
STRUCTURAL GENOMICS CENTERS FOR INFECTIOUS DISEASES - SARS-CoV-2 RESEARCH
$1,629,697Peter Myler · Seattle Children'S Hospital · N01 · FY2020 · AI
Mechanisms of Viral Pathogenesis in the Central Nervous System
$1,626,468Karin Peterson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Novel Protease Inhibitors as SARS Therapeutics
$1,621,464University Of Illinois At Chicago · P01 · FY2005 · AI
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) alters atherosclerotic plaque progression
$1,620,596Leslee J Shaw · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · HL
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19
$1,619,520Charles Yen Chiu · University Of California, San Francisco · R33 · FY2023 · HD
Towards high-resolution structural biology of membrane protein complexes in their native lipid environment
$1,618,890Doreen Matthies · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Human Biomimetics for Mucosal Infections
$1,618,266Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2021 · AI
Structure and Function of Membrane Proteins
$1,616,783Miguel Holmgren · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Alive Church Network: Increasing COVID-19 Testing in Chicago's African American Testing Deserts
$1,616,709Elizabeth B Lynch · Rush University Medical Center · R01 · FY2021 · NR
IMMUNE GLOBULIN FOR COVID-19 - UNITED STATES DEPARTMENT OF DEFENSE
$1,616,000Katy Saliba · National Institute Of Allergy And Infectious Diseases · Y01 · FY2021 · AI
Emerging infections: surveillance, epidemiology and pathogenesis
$1,615,955David Wang · Washington University · U01 · FY2024 · AI
Emerging infections: surveillance, epidemiology and pathogenesis
$1,614,920David Wang · Washington University · U01 · FY2021 · AI
Vasculitis and Translational Medicine
$1,614,493Peter Grayson · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
Rare & Mosaic Disorders - Clinical Research
$1,613,771Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2022 · HG
Emerging infections: surveillance, epidemiology and pathogenesis
$1,613,395David Wang · Washington University · U01 · FY2022 · AI
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system
$1,610,715Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · IP
RFA-IP-22-004, CORVETS - Cleveland Ohio Respiratory Viruses Vaccines Effectiveness across Traditional Risk Factors and Social Determinants of Health
$1,610,715Elie Saade · University Hospitals Of Cleveland · U01 · FY2025 · IP
RFA-IP-22-004, Multidisciplinary Approach to Understanding Vaccine Efficacy and Transmission of Viral Respiratory Tract Infections in the Real World
$1,610,715Stacey House · Washington University · U01 · FY2025 · IP
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19
$1,606,346Charles Yen Chiu · University Of California, San Francisco · R33 · FY2023 · HD
PPG: SARS-CoV-host cell interactions and vaccine development
$1,605,748Stanley Perlman · University Of Iowa · P01 · FY2013 · AI
West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health
$1,604,830Sally Lynn Hodder · West Virginia University · U54 · FY2023 · GM
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
$1,604,416Jonathan L. Haines · Case Western Reserve University · R01 · FY2022 · AG
HEALthy Brain and Child Development Study at UAB and UA
$1,603,131A. Myriam Peralta-Carcelen · University Of Alabama At Birmingham · U01 · FY2023 · DA
PPG: SARS-CoV-host cell interactions and vaccine development
$1,599,714Stanley Perlman · University Of Iowa · P01 · FY2011 · AI